ARS Pharmaceuticals (SPRY) Insider Trading & Ownership $13.12 -0.28 (-2.09%) (As of 09:47 AM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ARS Pharmaceuticals (NASDAQ:SPRY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage40.10%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$40.49 MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$12.83 M Get SPRY Insider Trade Alerts Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SPRY Insider Buying and Selling by Quarter Ad DTIAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.You need to check out the full story right here. ARS Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/20/2024Brian DorseyCOOSell50,000$15.00$750,000.00 8/20/2024Kathleen D ScottCFOSell12,500$16.00$200,000.00 8/20/2024Richard E LowenthalCEOSell100,000$15.03$1,503,000.00 8/19/2024Eric KarasInsiderSell10,000$14.00$140,000.00 7/16/2024Richard E LowenthalCEOSell100,000$11.40$1,140,000.00 7/9/2024Sarina TanimotoInsiderSell100,000$9.62$962,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/12/2024Sarina TanimotoInsiderSell95,862$9.15$877,137.30 6/11/2024Richard E LowenthalCEOSell4,138$9.00$37,242.00 5/16/2024Sarina TanimotoInsiderSell89,096$9.06$807,209.76 5/15/2024Richard E LowenthalCEOSell5,147$9.05$46,580.35 5/14/2024Sarina TanimotoInsiderSell5,757$9.01$51,870.57 5/7/2024Sarina TanimotoInsiderSell100,000$9.34$934,000.00 4/16/2024Sarina TanimotoInsiderSell100,000$9.28$928,000.00 4/9/2024Richard E LowenthalCEOSell100,000$9.28$928,000.00 3/27/2024Ra Capital Management, L.P.DirectorBuy505,954$9.79$4,953,289.66 3/25/2024Ra Capital Management, L.P.DirectorBuy437,600$9.06$3,964,656.00 3/25/2024Richard E LowenthalCEOSell95,267$9.12$868,835.04 3/22/2024Sarina TanimotoInsiderSell2,343$9.02$21,133.86 3/21/2024Richard E LowenthalCEOSell472$9.00$4,248.00 3/19/2024Richard E LowenthalCEOSell1,918$9.03$17,319.54 3/15/2024Richard E LowenthalCEOSell96,756$9.14$884,349.84 3/14/2024Sarina TanimotoInsiderSell444$9.00$3,996.00 3/13/2024Richard E LowenthalCEOSell2,800$9.00$25,200.00 2/29/2024Richard E LowenthalCEOSell3,782$9.02$34,113.64 2/28/2024Sarina TanimotoInsiderSell98,778$9.02$890,977.56 2/26/2024Sarina TanimotoInsiderSell700$9.01$6,307.00 9/28/2023Alexander A FitzpatrickInsiderBuy40,000$3.62$144,800.00 9/21/2023Ra Capital Management, L.P.DirectorBuy2,700,000$3.03$8,181,000.00 9/1/2023Laura ShawverDirectorSell100,000$7.71$771,000.00 8/29/2023Ra Capital Management, L.P.DirectorBuy3,750,000$6.20$23,250,000.00 (Data available from 1/1/2013 forward) SPRY Insider Trading Activity - Frequently Asked Questions Who is on ARS Pharmaceuticals's Insider Roster? The list of insiders at ARS Pharmaceuticals includes Alexander A Fitzpatrick, Brian Dorsey, Eric Karas, Kathleen D Scott, Laura Shawver, Ra Capital Management, L.P., Richard E Lowenthal, and Sarina Tanimoto. Learn more on insiders at SPRY. What percentage of ARS Pharmaceuticals stock is owned by insiders? 40.10% of ARS Pharmaceuticals stock is owned by insiders. Learn more on SPRY's insider holdings. Which ARS Pharmaceuticals insiders have been buying company stock? The following insiders have purchased SPRY shares in the last 24 months: Alexander A Fitzpatrick ($144,800.00), Kathleen D Scott ($51,480.00), and Ra Capital Management, L.P. ($40,348,945.66). How much insider buying is happening at ARS Pharmaceuticals? Insiders have purchased a total of 7,441,804 SPRY shares in the last 24 months for a total of $40,545,225.66 bought. Which ARS Pharmaceuticals insiders have been selling company stock? The following insiders have sold SPRY shares in the last 24 months: Brian Dorsey ($750,000.00), Eric Karas ($140,000.00), Kathleen D Scott ($200,000.00), Laura Shawver ($2,276,913.11), Richard E Lowenthal ($5,488,888.41), and Sarina Tanimoto ($5,482,632.05). How much insider selling is happening at ARS Pharmaceuticals? Insiders have sold a total of 1,506,927 ARS Pharmaceuticals shares in the last 24 months for a total of $14,338,433.57 sold. More Insider Trading Tools from MarketBeat Related Companies: ADMA Insider Trading CRNX Insider Trading DYN Insider Trading BHVN Insider Trading TGTX Insider Trading ACLX Insider Trading IOVA Insider Trading MRUS Insider Trading XENE Insider Trading MLTX Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Small Cap Stocks Insiders Are Actively BuyingTop 2 High-Yield Stocks That Insiders Are BuyingInsider Selling: When It Matters and When It Doesn'tInsiders Sell These Tech Stocks, but Investors Shouldn’tWhat Does Market Rotation Mean for This Top AI Stock? This page (NASDAQ:SPRY) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredSilver Grab of the Decade?In a groundbreaking move, J.P. Morgan now possesses the largest amount of physical silver in recorded history…...Colonial Metals | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.